Disclosed positions

Estimated from their latest filings — positions may have changed since

$23.28M

combined est. value

Stock	Shares	Price	Value	Weight	As of
RXRXRECURSION PHARMACEUTICALS, INC.	6,258,287	$3.72	$23.28M	100%	2026-06-17

RXRX

RECURSION PHARMACEUTICALS, INC.

$23.28M

6,258,287 sh

All filings on record

Every Form 4 transaction we track for this filer

all 6buys 0sells 4

Stock	Transaction	Date	~6mo later
RXRXRECURSION PHARMACEUTICALS, INC.	Grant — · 88,424 sh	2026-06-17	—
RXRXRECURSION PHARMACEUTICALS, INC.	Sell $110.4K · 30,000 sh	2026-06-02	—
RXRXRECURSION PHARMACEUTICALS, INC.	Sell $924.0K · 220,000 sh	2026-02-03	—
RXRXRECURSION PHARMACEUTICALS, INC.	Sell $959.2K · 220,000 sh	2026-01-06	—
RXRXRECURSION PHARMACEUTICALS, INC.	Sell $961.4K · 220,000 sh	2025-12-02	—
RXRXRECURSION PHARMACEUTICALS, INC.	Grant — · 22,016 sh	2025-06-18	—

RXRXGrant

2026-06-17 · RECURSION PHARMACEUTICALS, INC.

88,424

—

RXRXSell

2026-06-02 · RECURSION PHARMACEUTICALS, INC.

$110.4K

—

RXRXSell

2026-02-03 · RECURSION PHARMACEUTICALS, INC.

$924.0K

—

RXRXSell

2026-01-06 · RECURSION PHARMACEUTICALS, INC.

$959.2K

—

RXRXSell

2025-12-02 · RECURSION PHARMACEUTICALS, INC.

$961.4K

—

RXRXGrant

2025-06-18 · RECURSION PHARMACEUTICALS, INC.

22,016

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.